Pharmaceutical giant AstraZeneca has agreed to pay nearly $34 million to the State of Texas to resolve allegations that the pharmaceutical company violated state health care fraud laws by providing illegal kickbacks to prescribers, according to Texas Attorney General (AG) Ken Paxton’s office. The settlement announced in June 2026 stems from a lawsuit filed under the Texas Health Care Program Fraud Prevention Act. The state accused the drugmaker of offering free nursing services and reimbursement support to doctors as inducements to prescribe AstraZeneca products, which were later billed to Texas Medicaid. Allegations Details According to the state’s complaint, AstraZeneca deployed…

Newswire

Features

The Latest